CURRICULUM VITAE
Michael N. Teng, Ph.D.
Joy McCann Culverhouse Airway Disease Tele.: 813-***-****
Research Center FAX: (813) 910-404
Division of Allergy & Immunology E-mail: abpwwe@r.postjobfree.com
Department of Internal Medicine
University of South Florida School of Medicine
12901 Bruce B. Downs Blvd. MDC 19
Tampa, FL 33612
EDUCATION
1988 Bachelor of Science, Life Sciences, Massachusetts Institute of Technology,
Cambridge, MA
1993 Doctor of Philosophy, Immunology, University of Chicago, Chicago, IL
PROFESSIONAL EXPERIENCE
1993 1996 Postdoctoral Fellow, Department of Neuropharmacology, The
Scripps Research Institute, La Jolla, CA.
1996 1998 Senior Staff Fellow, Respiratory Viruses Section, Laboratory of
Infectious Diseases, NIAID, NIH, Bethesda, MD
1998 2002 Research Fellow, Respiratory Viruses Section, Laboratory of
Infectious Diseases, NIAID, NIH, Bethesda, MD
2002 - 2010 Assistant Professor, Department of Biochemistry and Molecular
Biology, The Pennsylvania State University, University Park, PA.
Member, Huck Institute for Life Sciences, The Pennsylvania State
University, University Park, PA.
2004 2010 Member, Center for Molecular Immunology and Infectious Diseases,
The Pennsylvania State University, University Park, PA.
2010 present Assistant Professor, Department of Internal Medicine, University of
South Florida College of Medicine, Tampa, FL.
Joint appointments
Department of Molecular Medicine, University of South Florida
College of Medicine, Tampa, FL.
Michael N. Teng, Ph.D.
Department of Pharmaceutical Sciences, University of South Florida
College of Pharmacy, Tampa, FL.
Member, Nanomedicine Research Center, University of South
Florida, Tampa, FL.
MEMBERSHIPS
American Society for Microbiology, 2000 - present
American Society for Virology, 2004 - present
American Association for the Advancement of Science, 1994 present
-2-
Michael N. Teng, Ph.D.
TEACHING EXPERIENCE
Pennsylvania State University
Semester Course Name Credits Enrollment
(Grad/Undergrad)
Spring 2002 BMMB 600 Thesis Research (G) 1 1
Fall 2002 BMMB 600 Thesis Research (G) 1 1
MICRB 496H Independent Research 2 1
(Honor s thesis) (U)
Spring 2003 MICRB 415 General Virology (U) 3 59
MICRB 496H Independent Research 2 1
(Honor s thesis)
BMB/MICRB 496 Independent Research 2 2
(U)
BMMB 600 Thesis Research (G) 1 2
Fall 2003 BMMB/V Sc 515 Macrophage Biology 1 7
(G)
MICRB 496H Independent Research 2 1
(Honor s thesis) (U)
BMB/MICRB 496 Independent Research 2 2
(U)
BMMB 600 Thesis Research (G) 1 2
Spring 2004 MICRB 415 General Virology (U) 3 59
MICRB 496H Independent Research 2 1
(Honor s thesis)
BMB/MICRB 496 Independent Research 2 2
(U)
BMMB 600 Thesis Research (G) 1 3
Fall 2004 MICRB 496H Independent Research 2 1
(Honor s thesis) (U)
BMMB 600 Thesis Research (G) 1 3
Spring 2005 MICRB 415 General Virology (U) 3 76
BMB/MICRB 496H Independent Research 2 2
(Honor s thesis) (U)
BMB 496 Independent Research 2 1
(U)
BMMB/V Sci 516 Viral Evasion of 1 13
Immune Responses (G)
BMMB/IBIOS 600 Thesis Research (G) 1 4
Fall 2005 BMMB/V Sc 515 Macrophage Biology 1.5 9
(G)
BMB 496H Independent Research 2 1
(Honor s thesis) (U)
BMMB/IBIOS 600 Thesis Research (G) 1 4
-3-
Michael N. Teng, Ph.D.
TEACHING EXPERIENCE (cont.)
Spring 2006 MICRB 415 General Virology (U) 3 81
BMB 496H Independent Research 2 1
(Honor s thesis) (U)
BMMB/IBIOS 600 Thesis Research (G) 1 4
Fall 2006 BMB 496H Independent Research 2 1
(Honor s thesis) (U)
BMMB 600/601 Thesis Research (G) 1 2
Spring 2007 MICRB 415 General Virology (U) 3 54
BMB 496H Independent Research 2 1
(Honor s thesis) (U)
BMB 496 Independent Research 2 1
(U)
BMMB/V Sc 516 Viral Evasion of 1 11
Immune Responses (G)
BMMB 601 Thesis Research (G) 1 2
IBIOS 600 Thesis Research (G) 1 1
Fall 2007 BMMB 601 Thesis Research (G) 1 1
Spring 2008 MICRB 415 General Virology (U) 3 48
BMB 411 Bioethics (U) 1 17
BMMB 601 Thesis Research (G) 1 1
Fall 2008 BMMB 601 Thesis Research (G) 1 1
Spring 2009 MICRB 415 General Virology (U) 3 61
BMMB/V Sc 516 Viral Evasion of 1 5
Immune Responses (G)
Fall 2009 MICRB 411 Survey of Microbiology 1 14
Literature (U)
IBIOS 590 Colloquium (G) 2 27
Guest lectures in Viral Pathogenesis (MICRB 435), Introductory Immunology
(MICRB 411), Molecular Medicine (BMB 464).
Served on 15 graduate degree committees
Supervised 12 rotation students
-4-
Michael N. Teng, Ph.D.
University of South Florida
Semester Course Name
Fall 2010 GMS 7930 Signature Interdisciplinary Program in Allergy,
Immunology, and Infectious Diseases (SIPAIID)
Seminar Series
BMS 6920 Colloquium Years I and II: Nanomedicine
Spring 2011 GMS 7930 SIPAIID Seminar Series
GMS 6103 Foundations in Medical Microbiology and Immunology
(section director)
GMS 6110 Host-parasite Interactions (lecture)
Supervised 5 rotation students
Serving on 1 graduate degree committee
COURSES DEVELOPED
Pennsylvania State University
Redesigned the General Virology course and constructed a complete set of PowerPoint
slides for each lecture (> 45 different lectures).
Redesigned BMB 411 Survey of Biochemistry and Molecular Biology Literature into a
Bioethics course.
University of South Florida
Started a Selected Topics course (GMS 7930) for SIPAIID students (Fall 2010).
Helped design the virology module for Foundation of Medical Microbiology and
Immunology (GMS 6103) (Spring 2011).
-5-
Michael N. Teng, Ph.D.
GRADUATE STUDENTS SUPERVISED
Pennsylvania State University
Name Degree/Date Present position
Hyung-Suk Oh Ph.D. student, 2002-2004 Postdoctoral fellow, Harvard
Medical School
Catherine Hofstetter Ph.D. student, 2002 Postdoctoral fellow, Penn
State
Catherine Svabek Ph.D. student, 2006 Research assistant, NIAID
Andrew Gunderson Ph.D. student, 2006-2009 Ph.D. student, Penn State
Paul Minnich M.S., 12/2004 Pharm.D., Pharmacist, Las Vegas,
NV
Thesis title: Determining regions of the ectodomain of RSV G protein essential for
enhancing assembly and budding of RSV
Gregory Keil M.S., 5/2007 Research Scientist, Schering-
Plough Research Institute
Thesis title: Determining the contribution of respiratory syncytial virus G protein in the
processes of viral assembly and virion morphogenesis
Zhenhua Ling Ph.D., 1/2009 Postdoctoral fellow,
Shanghai
Thesis title: Functional study of the nonstructural proteins of human respiratory
syncytial virus (RSV)
University of South Florida
Name Degree/Date Present position
Jillian Whelan Ph.D. student, 2011 present
HONOR THESIS STUDENTS SUPERVISED
2002-2005 Matthew Cohen B.S. with honors in Microbiology (5/2005)
Currently Ph.D. student, Univ. of Pennsylvania
2004-2007 Chad Kuny B.S. with honors in Biochemistry (5/2007)
Currently Ph.D. student, Univ. of Wisconsin
-6-
Michael N. Teng, Ph.D.
RESEARCH SUPPORT
Ongoing
Title Akt as an antiviral drug target for respiratory syncytial virus (R01)
Sponsor NIAID, NIH
Duration 8/1/2009 7/31/2013
P.I. Michael N. Teng
Title Generation and in vitro characterization of F-protein mutant RSV-A strain
Sponsor Ablynx, NV
Duration 8/1/2011 2/28/2012
P.I. Michael N. Teng
Pending
Title Novel approaches toward developing RSV vaccines (P01)
Sponsor NIAID, NIH
Duration 9/1/2012 8/31/2017
P.I. Ralph A. Tripp (Michael N. Teng, director Core 2)
Title Understanding the modulation of host microRNA regulation of human
target genes by Respiratory Syncytial Virus (R21)
Sponsor NIAID, NIH
Duration 9/1/2012 8/31/2014
P.I. Ralph A. Tripp (Michael N. Teng, co-P.I.)
PATENT
Patent number US5,993,824 Production of attenuated respiratory syncytial virus
vaccines from cloned nucleotide sequences
Inventors: Brian R. Murphy, Peter L. Collins, Stephen S. Whitehead,
Alexander A. Bukreyev, Katalin Juhasz, Michael N. Teng
RESEARCH INTERESTS
Viral pathogenesis
Viral inhibition of innate immunity
Assembly and budding of enveloped viruses
-7-
Michael N. Teng, Ph.D.
PUBLICATIONS (peer-reviewed)
1. Haase VH, Snijders AJ, Cooke SM, Teng MN, Kaul D, LeBeau MM, Bruns
GAP, Bernards A. Alternatively spliced ltk mRNA in neurons predicts a receptor
with a large putative extracellular domain. Oncogene 1991; 6:2319-2325.
2. Teng MN, Park BH, Koeppen HKW, Tracey KJ, Fendly BF, Schreiber H. Long-
term inhibition of tumor growth by tumor growth by tumor necrosis factor in the
absence of cachexia or T cell immunity. Proc. Natl. Acad. Sci. USA 1991;
88:3535-3539.
3. Cheng J, Turksen K, Yu Q-C, Schreiber H, Teng M, Fuchs E. Cachexia and graft
versus host disease-type skin changes in keratin promoter-driven TNF-
transgenic mice. Genes Dev. 1992; 6(8):1444-1456.
4. Teng M, Turksen K, Jacobs CA, Fuchs E, Schreiber H. Prevention of runting and
cachexia by a chimeric TNF receptor-Fc protein. Clin. Immunol. Immunopath.
1993; 69:215-223.
5. Breder CD, Hazuka C, Ghayur T, Klug C, Huginin M, Yasuda K, Teng M, Saper
CB. Regional induction of tumor necrosis factor alpha expression in the mouse
brain following systemic lipopolysaccharide administration. Proc. Natl. Acad.
Sci. USA 1994; 91:113**-*****.
6. Davis JF, Castro AE, de la Torre JC, Scanes CG, Radecki SV, Vasillatos-
Younken JT, Doman JT, Teng M. Hypoglycemia enteritis, and spiking mortality
in Georgia broiler chickens: experimental reproduction in broiler breeder chicks.
Avian Dis. 1995; 39:162-174.
7. Davis JF, Castro AE, de la Torre JC, Barnes HJ, Doman JT, Metz M, Lu H, Yuen
S, Dunn PA, Teng MN. Experimental reproduction of severe hypoglycemia and
spiking mortality syndrome using field-derived and embryo-passaged
preparations. Avian Dis. 1996; 40:158-172.
8. Buesa-Gomez J*, Teng MN*, Oldstone CE, Oldstone MBA, de la Torre JC.
Variants able to cause growth hormone deficiency syndrome are present within
the disease-nil WE strain of lymphocytic choriomeningitis virus. J. Virol. 1996;
70:8988-8892. (*co-first authors)
9. Teng MN, Borrow P, Oldstone MBA, de la Torre JC. A single amino acid
change in the glycoprotein of lymphocytic choriomeningitis virus is associated
with the ability to cause growth hormone deficiency syndrome. J. Virol. 1996;
70:8438-8443.
10. Teng MN, Oldstone MBA, de la Torre JC. Suppression of lymphocytic
choriomeningitis virus - induced growth hormone deficiency syndrome by disease
- negative virus variants. Virology 1996; 223:113-119.
11. Teng MN, Collins PL. Identification of the respiratory syncytial virus proteins
required for formation and passage of helper-dependent infectious particles. J.
Virol. 1998; 72:5707-5716.
12. Teng MN, Collins PL. Altered growth characteristics of recombinant respiratory
syncytial viruses which do not produce the NS2 protein. J. Virol. 1999; 73:466-
473.
-8-
Michael N. Teng, Ph.D.
13. Whitehead SS, Bukreyev A, Teng MN, Firestone C-Y, St. Claire M, Elkins WR,
Collins PL, Murphy BR. Recombinant respiratory syncytial virus bearing a
deletion of either the NS2 or SH gene is attenuated in chimpanzees. J. Virol.
1999; 73:3438-3442.
14. Collins PL, Whitehead SS, Bukreyev A, Fearns R, Teng MN, Juhasz K, Chanock
RM, Murphy BR. Rational design of live-attenuated recombinant vaccine virus
for human respiratory syncytial virus by reverse genetics. Adv. Virus Res. 1999;
54:423-451.
15. Lee KJ, Novella IS, Teng MN, Oldstone MB, de la Torre JC. NP and L proteins
of lymphocytic choriomeningitis virus (LCMV) are sufficient for efficient
transcription and replication of LCMV genomic RNA analogs. J. Virol. 2000;
74:3470-3477.
16. Teng MN, Whitehead SS, Bermingham A, St Claire M, Elkins WR, Murphy BR,
Collins PL. Recombinant respiratory syncytial virus that does not express the
NS1 or M2-2 protein is highly attenuated and immunogenic in chimpanzees. J.
Virol. 2000; 74:9317-9321.
17. Teng MN, Whitehead SS, Collins PL. Contribution of the respiratory syncytial
virus G glycoprotein and its secreted and membrane-bound forms to virus
replication in vitro and in vivo. Virology 2001; 289:283-296.
18. Teng MN, Collins PL. The central conserved cystine noose of the attachment G
protein of human respiratory syncytial virus is not required for efficient viral
infection in vitro or in vivo. J. Virol. 2002; 76:6164-6171.
19. Polack FP, Teng MN, Collins PL, Prince GA, Exner M, Regele H, Lirman DD,
Rabold R, Hoffman SJ, Karp CL, Kleeberger SR, Wills-Karp M, Karron RA. A
role for immune complexes in enhanced respiratory syncytial virus disease. J.
Exp. Med. 2002; 196:859-865.
20. Spann KM, Collins PL, Teng MN. Genetic recombination during coinfection of
two mutants of human respiratory syncytial virus. J. Virol. 2003; 77:11201-
11211.
21. Tran K-C, Collins PL, Teng MN. Effects of altering the transcription termination
signals of respiratory syncytial virus (RSV) on viral gene expression and growth
in vitro and in vivo. J. Virol. 2004; 78:692-699.
22. Johnson TR, Teng MN, Collins PL, Graham BS. Immune responses to
respiratory syncytial virus (RSV) G glycoprotein are not necessary for formalin-
inactivated RSV vaccine-enhanced disease. J. Virol. 2004; 78:6024-6032.
23. Ghildyal R, Li D, Peroulis I, Shields B, Bardin PG, Teng MN, Collins PL,
Meanger J, and Mills J. Matrix protein of respiratory syncytial virus interacts
with the G glycoprotein cytoplasmic domain in the cytoplasm. J. Gen. Virol.
2005; 86:1879-1884.
24. Fuentes S., Tran KC, Teng MN, and He B. Function of the respiratory syncytial
virus small hydrophobic protein. J. Virol. 2007; 81:8361-8366.
25. Tran, KC, He B, and Teng MN. Replacement of the respiratory syncytial virus
nonstructural proteins NS1 and NS2 by the V protein of parainfluenza virus 5.
Virology 2007; 368:73-82.
-9-
Michael N. Teng, Ph.D.
26. Ling Z, Tran KC, Arnold JJ, Teng MN. Purification and biochemical
characterization of human respiratory syncytial virus nonstructural NS1 protein
produced in E. coli. Prot. Expr. Purif. 2008; 57:261-270.
27. Sun M, Fuentes SM, Timani K, Sun D, Murphy C, Lin Y, August A, Teng MN,
He, B. Akt plays a critical role in replication of non-segmented negative stranded
RNA viruses. J. Virol. 2008; 82:105-114.
28. Ling Z, Tran KC, Teng MN. The human respiratory syncytial virus nonstructural
NS2 protein antagonizes interferon-beta activation by binding RIG-I. J. Virol,
2009; 83:3734-42.
29. Ghildyal R, Ho A, Dias M, Soegiyono L, Bardin PG, Tran KC, Teng MN, Jans
DA. The respiratory syncytial virus matrix protein possesses a Crm1-mediated
nuclear export mechanism. J. Virol. 2009; 83:5353-5362.
30. Hanley LL, McGivern DR, Teng MN, Djang R, Collins PL, Fearns R. Roles of
the respiratory syncytial virus trailer region: effects of mutations on genome
production and stress granule formation. Virology 2010; 406:241-252.
REVIEWS
1. Teng MN. The non-structural proteins of RSV: targeting interferon antagonists
for vaccine development. Infectious Disorders-Drug Targets 2012, in press.
BOOK CHAPTERS
1. Schreiber H, Gressler VH, Teng MN, Rothstein JL, Rowley DA. Cytokines as
effectors in tumor immunity. In Immunology and Allergy Clinics of North
America (H. Oettgen, ed.) 1990; 10:747-764.
2. Teng MN. Live attenuated respiratory syncytial virus vaccines. In Replicating
vaccines (PR Dormitzer, CW Mandl, R. Rappuoli, eds.) 2011, ISBN 978-3-0346-
0276-1.
- 10 -
Michael N. Teng, Ph.D.
INVITED SEMINAR PRESENTATIONS
Mount Sinai Medical School, Dept. of Microbiology, New York, NY, "Role of the
attachment and nonstructural proteins in respiratory syncytial virus infection," January
24, 2000.
Johns Hopkins University, Dept. of Molecular Microbiology and Immunology,
Baltimore, MD, "Role of the attachment and nonstructural proteins in respiratory
syncytial virus infection," July 13, 2000.
Indiana University, Dept. of Biology, Bloomington, IN, "Role of the attachment and
nonstructural proteins in respiratory syncytial virus infection," January 17, 2001.
The Pennsylvania State University, Dept. of Biochemistry and Molecular Biology,
University Park, PA, "Role of the attachment and nonstructural proteins in respiratory
syncytial virus infection," February 5, 2001.
Harvard Medical School, Dept. of Microbiology and Immunology, Cambridge, MA,
"Role of the attachment and nonstructural proteins in respiratory syncytial virus
infection," February, 2001
The Pennsylvania State University, College of Medicine, Dept. of Microbiology and
Immunology, Hershey, PA, "Pathogenesis of respiratory syncytial virus infection," April
10, 2003.
The Pennsylvania State University, Penn State Cancer Institute, University Park, PA,
Pathogenesis of respiratory syncytial virus infection, July 27, 2005.
Columbus Children s Research Institute, Dept. of Immunology, Columbus, OH.
Characterization of the nonstructural proteins of human respiratory syncytial virus,
October 6, 2005.
The Pennsylvania State University, College of Medicine, Dept. of Microbiology and
Immunology, Hershey, PA, Characterization of the nonstructural proteins of human
respiratory syncytial virus, March 8, 2006.
Queen s University, Centre for Cancer Research and Cell Biology, Belfast, N. Ireland,
Characterization of the nonstructural proteins of human respiratory syncytial virus,
May 4, 2006.
University of Dundee, Department of Molecular and Cellular Pathology, Dundee, UK,
Characterization of the nonstructural proteins of human respiratory syncytial virus,
May 8, 2006.
- 11 -
Michael N. Teng, Ph.D.
The Pennsylvania State University, Huck Institute for Life Sciences, University Park, PA,
CrossOver 2006, Viral inhibition of interferon responses, October 12, 2006.
MedImmune, Inc., Gaithersburg, MD, Characterization of the nonstructural proteins of
human respiratory syncytial virus, October 26, 2006.
The Pennsylvania State University, Penn State Cancer Institute, VOHD Retreat,
University Park, PA, Multiple effects of the respiratory syncytial virus nonstructural
proteins on interferon activation, April 23, 2008.
University of British Columbia, Department of Microbiology, Vancouver, BC, Multiple
effects of the respiratory syncytial virus nonstructural proteins on viral pathogenesis,
October 14, 2008.
Novartis Institute for Biomedical Research, Virology Group, Cambridge, MA, Multiple
effects of the respiratory syncytial virus nonstructural proteins on viral pathogenesis,
December 5, 2008.
University of South Florida, Signature Interdisciplinary Program in Allergy,
Immunology, and Infectious Disease Seminar Series, Tampa, FL, Multiple effects of the
respiratory syncytial virus nonstructural proteins on viral pathogenesis, June 22, 2009.
University of South Florida School of Medicine, Department of Internal Medicine,
Tampa, FL, Multiple effects of the respiratory syncytial virus nonstructural proteins on
viral pathogenesis, August 18, 2009.
University of Georgia School of Veterinary Medicine, Department of Infectious Diseases,
Athens, GA, Multiple effects of the respiratory syncytial virus nonstructural proteins on
viral pathogenesis, September 21, 2009.
Millersville University, Department of Biology, Lancaster, PA, Vaccine research:
human respiratory syncytial virus as a case study, December 2, 2009.
Second Greater Boston Symposium on Vaccine Science, Norton s Woods Conference
Center at The American Academy of Arts and Sciences, Cambridge, MA, Engineered
live attenuated respiratory syncytial virus vaccines, April 27, 2010.
University of South Florida, Division of Allergy and Immunology Retreat, CRI, St.
Petersburg, FL, Akt signaling in RSV infection, May 8, 2010.
University of South Florida, Signature Interdisciplinary Program in Allergy,
Immunology, and Infectious Diseases Seminar Series, USF Health, Tampa, FL,
Multifunctional viral proteins in the pathogenesis of infection, May 27, 2010.
University of South Florida College of Medicine, Grand Rounds, Tampa, FL, Viral
vaccines, July 29, 2010.
- 12 -
Michael N. Teng, Ph.D.
University of South Florida, Department of Molecular Medicine Seminar Series, USF
Health, Tampa, FL, Multifunctional viral proteins in the pathogenesis of RSV
infection, September 1, 2010.
University of Southern California, Department of Molecular and Computational Biology,
Los Angeles, CA, Multifunctional proteins: how viruses can expand their coding
capacities, October 28, 2011.
University of Georgia, Department of Infectious Diseases, School of Veterinary
Medicine, Athens, GA, Dissecting the multiple functions of the respiratory syncytial
virus nonstructural proteins, October 31, 2011.
- 13 -
Michael N. Teng, Ph.D.
SERVICE (PROFESSIONAL)
Reviewer for professional journals (ad hoc)
PLoS Pathogens, Journal of Virology, Virology, Virus Research, FEMS Reviews
Journal of Biological Chemistry, The Protein Journal, Experimental Cell Research,
Journal of General Virology
Reviewer for textbooks
Wise, J. 2003. The Viruses: Prototypes and Principles . Pearson Prentice Hall.
Acheson, N. 2003. Fundamentals of Molecular Virology . John Wiley & Sons.
Shors, T. 2005. Understanding Viruses . Jones & Bartlett.
Wagner, E., et al. 2005. Basic Virology . Blackwell.
Reviewer for research proposals
American Heart Association, Mid-Atlantic Affiliate, 2006-7
American Heart Association, Great Rivers Affiliate, 2008-9
US-Israel Binational Science Foundation, 2004
Conference organizing
Member, Organizing Committee, American Society for Virology National Meeting held
at Penn State, June 18 22, 2005.
SERVICE (Pennsylvania State University)
Departmental
Member Candidacy Committee, 2003-2005
Member Post Tenure Review Committee, 2005-2007
Member Graduate Advisory Committee, 2009-2010
University
Member Candidacy Committee (Integrated Biosciences Graduate Degree Program,
Immunobiology option), 2003-2005
Member Candidacy Committee (Integrated Biosciences Graduate Degree Program,
Molecular Medicine option), 2004-2006
Member Nominating committee, Paul Berg Prize in Molecular Biology, 2005-2006,
2008 (Chair)
Member Nominating committee, Chemerda Lecture, 2008
Chair Student Guidance Committee (Integrated Biosciences Graduate Degree
Program, Molecular Medicine option), 2003-2004
Judge Schreyer Honors College poster exhibition, 2003
Outreach
Faculty participant Action Potential Science Program, 2005-2006
Mentor McNair Scholars program, 2002
- 14 -
Michael N. Teng, Ph.D.
SERVICE (University of South Florida)
Member Institutional Biosafety Committee, 2011 present
Member Molecular Medicine faculty search committee, 2011 present
Member Signature Interdisciplinary Programs in Allergy, Immunology, and
Infectious Diseases Executive Committee, 2010 present
Coordinator Division of Allergy and Immunology Research Conference, 2011
present
Judge USF Health Research Day, 2011
- 15 -